ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharmaceuticals gets USFDA tentative nod for generic cancer treatment drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its Bosutinib tablets. These tablets are used to treat certain types of cancer, specifically chronic myelogenous leukemia. The approval covers the 400 mg strength. This development m
Announcement as on 12 January 2026

Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injection
Alembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatriptan autoinjector. This achievement signifies the company's inaugural foray into drug-device combo products, aimed at al
Announcement as on 10 November 2025

Alembic Pharmaceuticals gets USFDA nod for generic blood cancer treatment drug
Alembic Pharmaceuticals has secured final approval from the USFDA for its generic Dasatinib tablets. These tablets are used to treat certain blood cancers in adults and children. The approval covers multiple strengths of the drug. Dasatinib is a vital medi
Announcement as on 07 November 2025

Alembic Pharma gets USFDA nod for generic drug to treat depression, anxiety
Alembic Pharmaceuticals Ltd. announced it has secured final approval from the USFDA for its generic Paroxetine extended-release tablets, available in 25 mg and 37.5 mg strengths. These tablets are therapeutically equivalent to Apotex Inc's Paxil CR and ind
Announcement as on 25 September 2025

Alembic gets USFDA nod for generic drug for skin condition
Alembic Pharmaceuticals has secured USFDA approval for its generic Tretinoin Cream USP (0.025%), a treatment for acne vulgaris. This ANDA is therapeutically equivalent to Bausch Health US, LLC's Retin-A Cream. The market size for Tretinoin cream USP (0.025
Announcement as on 18 August 2025

Announcements by Alembic Ltd. first page | Next page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 94.41
  • 12Day Average: 97.3
  • 20Day Average: 98.86
  • 50Day Average: 99.7
  • 100Day Average: 100.92
  • 150Day Average: 105.27
  • 200Day Average: 105.38

506235 Indicators & signals

Indicator MACD (12,26,9)

96.37, 98.24, -0.93
Indicator MACD is in negative zone

Indicator ADX (14)

45.76, 13.85, 37.23
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Wed Jan 2026 91.30 89.75 to 95.45 -0.6% 1.38 times
20 Tue Jan 2026 91.85 91.45 to 95.10 -3.37% 1.41 times
19 Mon Jan 2026 95.05 94.95 to 96.00 -1.25% 0.5 times
16 Fri Jan 2026 96.25 95.60 to 98.05 -1.38% 0.97 times
14 Wed Jan 2026 97.60 97.45 to 98.50 -0.46% 0.93 times
13 Tue Jan 2026 98.05 97.50 to 99.25 0.15% 0.52 times
12 Mon Jan 2026 97.90 97.00 to 98.50 -0.2% 1.16 times
09 Fri Jan 2026 98.10 96.80 to 99.40 -0.51% 2.48 times
08 Thu Jan 2026 98.60 98.30 to 100.65 -1.94% 1.16 times
07 Wed Jan 2026 100.55 100.05 to 101.40 0% 0.45 times
06 Tue Jan 2026 100.55 100.25 to 101.80 -1.18% 0.42 times
05 Mon Jan 2026 101.75 101.50 to 104.25 -1.6% 0.88 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top